Half a million asthma sufferers in the UK could benefit from a "breakthrough" drug that reduces complications caused by the common cold, it was claimed today.
Severe symptoms due to cold infections are one of the chief reasons why asthma patients end up in hospital.
A trial of the new drug, SNG001, at Southampton University, found it significantly reduced asthma symptoms during the critical first week of infection.
Treatment led to a 65% reduction in the number of patients experiencing moderate worsening of symptoms.
More top news
Wednesday night's weather for the east of the region
Wednesday night's weather for the west of the region
It'll be alright on the night! Piece to camera filming gets photo-bombed by excitable solstice visitors